Ebenezer David
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
Papers in
-
- Multiple Myeloma Research and Treatments 4
-
- SARS-CoV-2 and COVID-19 Research 3
- SARS-CoV-2 detection and testing 2
- Co-authors
- R. B. Carroll (2 shared papers)E V Sorokina (2 shared papers)Beatriz M. A. Fontoura (2 shared papers)Sagar Lonial (11 shared papers)Patrick Hearing (3 shared papers)Edmund K. Waller (3 shared papers)Elizabeth A. Eklund (1 shared paper)Renu Kakar (1 shared paper)
- Journals
- Blood (9 papers)Molecular and Cellular Biology (4 papers)Journal of Biological Chemistry (2 papers)Clinical Infectious Diseases (2 papers)The Journal of Pediatrics (1 paper)
- Partner nations
- United StatesUgandaPoland
In The Last Decade
Ebenezer David
25 papers receiving 873 citations
Peers
Comparison fields: 5 of 89
- Modeling and Simulation 71
- Infectious Diseases 248
- Hematology 93
- Oncology 189
- Immunology 110
Countries citing papers authored by Ebenezer David
This map shows the geographic impact of Ebenezer David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebenezer David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebenezer David more than expected).
Fields of papers citing papers by Ebenezer David
This network shows the impact of papers produced by Ebenezer David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebenezer David. The network helps show where Ebenezer David may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebenezer David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 165 | |
| 2 | 2022 | 94 | |
| 3 | 1992 | 93 | |
| 4 | 2020 | 74 | |
| 5 | 1993 | 69 | |
| 6 | 2001 | 59 | |
| 7 | 2005 | 49 | |
| 8 | 2011 | 46 | |
| 9 | 1992 | 39 | |
| 10 | 2008 | 35 | |
| 11 | 1998 | 31 | |
| 12 | 1993 | 27 | |
| 13 | 2010 | 22 | |
| 14 | 1995 | 22 | |
| 15 | 2022 | 17 | |
| 16 | 2008 | 12 | |
| 17 | 2022 | 12 | |
| 18 | 2022 | 7 | |
| 19 | 2007 | 5 | |
| 20 | 2008 | 4 |
About Ebenezer David
Ebenezer David is a scholar working on Hematology, Infectious Diseases, Molecular Biology, Immunology and Cancer Research, having authored 25 papers that have together received 897 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), RNA Interference and Gene Delivery (4 papers), Multiple Myeloma Research and Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cell death mechanisms and regulation (2 papers), Protein Degradation and Inhibitors (2 papers), SARS-CoV-2 detection and testing (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Modeling and Simulation (71 citations), Infectious Diseases (248 citations), Hematology (93 citations), Oncology (189 citations) and Immunology (110 citations). Ebenezer David has collaborated with scholars based in United States, Uganda and Poland. Frequent co-authors include R. B. Carroll, E V Sorokina, Beatriz M. A. Fontoura, Sagar Lonial, Patrick Hearing, Edmund K. Waller, Elizabeth A. Eklund, Renu Kakar, P. Emery and Walter Reith. Their work appears in journals such as Blood, Molecular and Cellular Biology, Journal of Biological Chemistry, Clinical Infectious Diseases and The Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.